Earnings FeedTerminal

⌘K

Home/Insiders/Hansen Gwenn

HG

SEC Insider//CIK 0001817160

Hansen Gwenn

CIK 00018171601 companySAN FRANCISCO, CA

Transactions

9

Companies

1

Filings

2

CIK

0001817160

Recent Transactions

9 trades

Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2023-01-30−3,207→ 38,481 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2023-01-30−3,207→ 38,481 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2023-01-30+3,207→ 24,421 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2023-01-30$11.78/sh−1,412→ 23,009 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2023-01-30+3,207→ 24,421 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2023-01-30$11.78/sh−1,412→ 23,009 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Employee Stock Option (right to buy)
2021-09-07−1,600→ 69,466 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2021-09-07$7.26/sh+1,600→ 15,797 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2021-09-07$35.00/sh−1,600→ 14,197 total

Companies

1

Nurix Therapeutics, Inc.
Chief Scientific Officer
$NRIX

Recent Filings

2

Address

C/O NURIX THERAPEUTICS, INC. 1700 OWENS STREET, SUITE 205

SAN FRANCISCO, CA, 94158

View on SEC.gov